![IoTeX 🔜 EthCC 🇫🇷 on Twitter: "Introducing our revamped staking portal under a brand new URL: https://t.co/NXChya1qzg! 🌐 View all of your staking rewards + Burn-Drop rewards in one clean interface, and IoTeX 🔜 EthCC 🇫🇷 on Twitter: "Introducing our revamped staking portal under a brand new URL: https://t.co/NXChya1qzg! 🌐 View all of your staking rewards + Burn-Drop rewards in one clean interface, and](https://pbs.twimg.com/media/E_LwvHJVcAA_Lsx.jpg)
IoTeX 🔜 EthCC 🇫🇷 on Twitter: "Introducing our revamped staking portal under a brand new URL: https://t.co/NXChya1qzg! 🌐 View all of your staking rewards + Burn-Drop rewards in one clean interface, and
![EZM2302 is orally available with potent in vivo CARM1 inhibition. (a)... | Download Scientific Diagram EZM2302 is orally available with potent in vivo CARM1 inhibition. (a)... | Download Scientific Diagram](https://www.researchgate.net/publication/321847728/figure/fig3/AS:579251116179456@1515115636016/EZM2302-is-orally-available-with-potent-in-vivo-CARM1-inhibition-a-Preclinical-PK-of.png)
EZM2302 is orally available with potent in vivo CARM1 inhibition. (a)... | Download Scientific Diagram
![NephroPOCUS on Twitter: "#POCUS answer: 1. Portal vein 2. Inferior vena cava #MedEd #IMPOCUS https://t.co/QOFCRdNKOo" / Twitter NephroPOCUS on Twitter: "#POCUS answer: 1. Portal vein 2. Inferior vena cava #MedEd #IMPOCUS https://t.co/QOFCRdNKOo" / Twitter](https://pbs.twimg.com/media/FzHQQtbWIAEzEkB.jpg)